It is rare for me to print things anymore; limited access to a giant corporate printer cuts down on the urge. But today I got the printer going, grabbed the highlighter and dug in. The paper? “Is the price right? Paying for value today to get more value tomorrow.” If I were a health policy…
InNOvation. Seagen said they aren’t looking at a drug that would treat early-stage bladder cancer because it would be subject to negotiation too soon after approval and wouldn’t have a financial return on the investment. Today the National Pharmaceutical Council published a great piece in Health Affairs that goes deeper into the subject of innovation…
A few weeks ago I watched novelist John Green get emotional in a YouTube video about the price of a tuberculosis test by Cepheid. The gist is that the TB test costs $10 while (likely) costing less than $5 to produce. There is acknowledgement that the product is “incredible, amazing, wonderous.” But it should be…